| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |